SFA Therapeutics
Regulating the immune system to block cancer & autoimmune diseases
SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.
- Website
- sfatherapeutics.com
- City
- Philadelphia
- Country
- United States
- YC batch
- Summer 2021
- Team
- 4 people
- Stage
- Early stage
- AI-native
- No
More Health & bio in Philadelphia
Vitable HealthHiring
Affordable care via ICHRA and primary care with visits, meds, labs…
OrchidHiring
AI-powered EHR for independent mental health professionals
Biocartesian
Converting biology into digital molecular maps
Spark Therapeutics (United States)
Company in Philadelphia, United States.
Claim this profile
Free and instant: prove you run sfatherapeutics.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to SFA Therapeutics across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with SFA Therapeutics's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
